Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Prelamin A and lamin A appear to be dispensable in the nuclear lamina
Loren G. Fong, … , Martin O. Bergo, Stephen G. Young
Loren G. Fong, … , Martin O. Bergo, Stephen G. Young
Published March 1, 2006
Citation Information: J Clin Invest. 2006;116(3):743-752. https://doi.org/10.1172/JCI27125.
View: Text | PDF
Research Article Genetics Article has an altmetric score of 7

Prelamin A and lamin A appear to be dispensable in the nuclear lamina

  • Text
  • PDF
Abstract

Lamin A and lamin C, both products of Lmna, are key components of the nuclear lamina. In the mouse, a deficiency in both lamin A and lamin C leads to slow growth, muscle weakness, and death by 6 weeks of age. Fibroblasts deficient in lamins A and C contain misshapen and structurally weakened nuclei, and emerin is mislocalized away from the nuclear envelope. The physiologic rationale for the existence of the 2 different Lmna products lamin A and lamin C is unclear, although several reports have suggested that lamin A may have particularly important functions, for example in the targeting of emerin and lamin C to the nuclear envelope. Here we report the development of lamin C–only mice (Lmna+/+), which produce lamin C but no lamin A or prelamin A (the precursor to lamin A). Lmna+/+ mice were entirely healthy, and Lmna+/+ cells displayed normal emerin targeting and exhibited only very minimal alterations in nuclear shape and nuclear deformability. Thus, at least in the mouse, prelamin A and lamin A appear to be dispensable. Nevertheless, an accumulation of farnesyl–prelamin A (as occurs with a deficiency in the prelamin A processing enzyme Zmpste24) caused dramatically misshapen nuclei and progeria-like disease phenotypes. The apparent dispensability of prelamin A suggested that lamin A–related progeroid syndromes might be treated with impunity by reducing prelamin A synthesis. Remarkably, the presence of a single LmnaLCO allele eliminated the nuclear shape abnormalities and progeria-like disease phenotypes in Zmpste24–/– mice. Moreover, treating Zmpste24–/– cells with a prelamin A–specific antisense oligonucleotide reduced prelamin A levels and significantly reduced the frequency of misshapen nuclei. These studies suggest a new therapeutic strategy for treating progeria and other lamin A diseases.

Authors

Loren G. Fong, Jennifer K. Ng, Jan Lammerding, Timothy A. Vickers, Margarita Meta, Nathan Coté, Bryant Gavino, Xin Qiao, Sandy Y. Chang, Stephanie R. Young, Shao H. Yang, Colin L. Stewart, Richard T. Lee, C. Frank Bennett, Martin O. Bergo, Stephen G. Young

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 4 7 4 8 4 7 8 3 7 4 10 3 10 8 6 5 10 6 3 118
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2012 (10)

Title and authors Publication Year
Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna−/− Mice
RL Frock, SC Chen, DF Da, E Frett, C Lau, C Brown, DN Pak, Y Wang, A Muchir, HJ Worman, LF Santana, WC Ladiges, PS Rabinovitch, BK Kennedy
PloS one 2012
Nuclear Lamins in the Brain — New Insights into Function and Regulation
HJ Jung, JM Lee, SH Yang, SG Young, LG Fong
Molecular Neurobiology 2012
The nuclear lamins: flexibility in function
B Burke, CL Stewart
Nature Reviews Molecular Cell Biology 2012
Lamin B1 loss is a senescence-associated biomarker
A Freund, RM Laberge, M Demaria, J Campisi, TM Magin
Molecular biology of the cell 2012
Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn
J Reunert, R Wentzell, M Walter, S Jakubiczka, M Zenker, T Brune, S Rust, T Marquardt
European Journal of Human Genetics 2012
Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA
HJ Jung, C Coffinier, Y Choe, AP Beigneux, BS Davies, SH Yang, RH 2nd, J Hong, T Sun, SJ Pleasure, SG Young, LG Fong
Proceedings of the National Academy of Sciences 2012
Alternative nuclear transport for cellular protein quality control
A Rose, C Schlieker
Trends in Cell Biology 2012
Understanding the roles of nuclear A- and B-type lamins in brain development
SG Young, HJ Jung, C Coffinier, LG Fong
The Journal of biological chemistry 2012
Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice
J Liao, YT Chung, AL Yang, M Zhang, H Li, W Zhang, L Yan, GY Yang
Molecular Carcinogenesis 2012
Type-I Prenyl Protease Function Is Required in the Male Germline of Drosophila melanogaster
K Adolphsen, A Amell, N Havko, S Kevorkian, K Mears, H Neher, D Schwarz, SR Schulze
G3: Genes|Genomes|Genetics 2012

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
Highlighted by 1 platforms
197 readers on Mendeley
See more details